These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19682884)
1. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany. Diel R; Schaberg T; Loddenkemper R; Welte T; Nienhaus A Respir Med; 2009 Dec; 103(12):1838-53. PubMed ID: 19682884 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection. Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Diel R; Nienhaus A; Loddenkemper R Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts. Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda. Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453 [TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Oxlade O; Schwartzman K; Menzies D Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815 [TBL] [Abstract][Full Text] [Related]
8. Cost-optimisation of screening for latent tuberculosis in close contacts. Diel R; Nienhaus A; Lange C; Schaberg T Eur Respir J; 2006 Jul; 28(1):35-44. PubMed ID: 16571615 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345 [TBL] [Abstract][Full Text] [Related]
10. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay]. Harada N Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047 [TBL] [Abstract][Full Text] [Related]
11. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944 [TBL] [Abstract][Full Text] [Related]
12. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Diel R; Nienhaus A; Lange C; Meywald-Walter K; Forssbohm M; Schaberg T Respir Res; 2006 May; 7(1):77. PubMed ID: 16707012 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil. Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers. del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360 [TBL] [Abstract][Full Text] [Related]
15. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555 [TBL] [Abstract][Full Text] [Related]
16. Use of the QuantiFERON-TB Gold test to confirm latent tuberculosis infection in a Canadian tuberculosis clinic. Kunimoto D; Der E; Beckon A; Thomas L; Egedahl M; Beatch A; Williams G; Tyrrell G; Ahmed R; Brown N; Long R Int J Tuberc Lung Dis; 2009 Jun; 13(6):726-30. PubMed ID: 19460248 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Lee SS; Liu YC; Huang TS; Chen YS; Tsai HC; Wann SR; Lin HH Scand J Infect Dis; 2008; 40(5):373-80. PubMed ID: 18418798 [TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327 [TBL] [Abstract][Full Text] [Related]
19. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases. Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300 [TBL] [Abstract][Full Text] [Related]
20. [Effects of prophylaxis on QuantiFERON TB-2G responses among children]. Higuchi K; Okada K; Harada N; Mori T Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]